FIGURE 1.
Kaplan-Meier curves comparing RFS (A) and OS (B) for disappearing (blue) versus persistent (red) RLPN after neoadjuvant therapy. RFS, recurrence-free survival; RLPN, retroperitoneal and lateral pelvic lymph nodes; OS, overall survival
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.